Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NextEra Energy, Inc. (NEE) vs GeneDx Holdings Corp (WGS) Price & Performance

NextEra Energy, Inc.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

NextEra Energy, Inc. vs GeneDx Holdings Corp — how do they compare? NextEra Energy, Inc. trades at $85.81 (market cap $176.68B), while GeneDx Holdings Corp trades at $81.98 (market cap $2.32B). The key difference: NextEra Energy, Inc. is far larger — about 76.2× GeneDx Holdings Corp's market cap, and NextEra Energy, Inc. pays a 2.94% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

NEEWGS
Market Cap
$176.68B$2.32B
Sector
UtilitiesTechnology
52-Week High
$97.88$167.51
52-Week Low
$69.77$34.51
Enterprise Value
$284.01B$2.35B
Dividend Yield
2.94%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NextEra Energy, Inc.

NextEra Energy (NEE) trades at $84.65, showing minimal daily movement with a 0.06% gain. The stock is in a bearish technical phase, with support at $84 and resistance at $86. Recent earnings beat expectations in Q1 and Q2 2026, while Q4 2025 missed. The company benefits from strong AI-driven power demand, highlighted by a $100 billion data center project in Kentucky announced on July 29, 2026 (Reuters).

NEE offers solid fundamentals with a 32.4% net income margin and 17.23% ROE, but faces risks from high debt levels and capital expenditures. Analysts are bullish with a $101.17 consensus price target, implying 19% upside. Key opportunities include AI infrastructure growth, while risks involve execution on large projects and interest rate sensitivity.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.

Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.

Returns comparison

Trailing returns across standard periods

About NextEra Energy, Inc.

NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.

Read more on NEE

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS